N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus.
about
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesImmunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing EpitopesStabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in HIV-1 envelope glycoproteinGeneration and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern AfricaElicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoproteinFunctional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1)Effect of trimerization motifs on quaternary structure, antigenicity, and immunogenicity of a noncleavable HIV-1 gp140 envelope glycoprotein.In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1Novel recombinant engineered gp41 N-terminal heptad repeat trimers and their potential as anti-HIV-1 therapeutics or microbicidesIncreased functional stability and homogeneity of viral envelope spikes through directed evolution.Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein.Native-like Env trimers as a platform for HIV-1 vaccine design.Potential of carbohydrate-binding agents as therapeutics against enveloped viruses.Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at its Apex.A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers.Evolution of New Variants/Mutants of JE Virus, Its Effect on Neurovirulence, Antigenicity, Host Immune Responses and Disease Transmission in Endemic Areas
P2860
Q27318508-8B865550-324D-499F-8F7B-D31C5D3B165DQ28271300-E7D2B162-34D5-430A-9C4C-FF4803C86C71Q28534454-1D78FB70-EDBC-494F-B2E6-F5F0882288E4Q28552786-3AC1AC4B-92AF-4643-BAA8-8D3EB3BEF3CAQ28732438-18AF6E5C-ADDB-4401-8FFA-E97D9E8401C8Q28743199-14B6CF36-10B8-4311-AA0F-8A4A67D8E21BQ33571825-C54782DE-60E1-4BBB-B3BA-93C22B9C5DF0Q33725718-72A5CA0A-CE91-4175-80A1-1AEE3E6B660FQ34055847-0A8055D3-A5C0-4E3A-B644-C7934A49648BQ34611144-A9FB0D8F-D1F2-4E78-A258-CF9FBE7102ACQ37123584-7131E3DF-0FB7-484D-BB56-A33C9CDA2C99Q37633417-B2E4D10E-56F6-4887-A563-08E837B8C845Q37767654-367F64CE-78C8-4E8A-8D1C-6DE92BC4C4DEQ41924154-93037D32-D6F7-409F-8BAE-D9C9D6A74EEAQ54237723-8AAEC060-B1E6-453C-8FDB-D4D6BAE73EE9Q59049769-0D8F8A9A-2139-4802-B979-F7DDB4C10CF5
P2860
N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
N-terminal substitutions in HI ...... pe glycoproteins on the virus.
@ast
N-terminal substitutions in HI ...... pe glycoproteins on the virus.
@en
type
label
N-terminal substitutions in HI ...... pe glycoproteins on the virus.
@ast
N-terminal substitutions in HI ...... pe glycoproteins on the virus.
@en
prefLabel
N-terminal substitutions in HI ...... pe glycoproteins on the virus.
@ast
N-terminal substitutions in HI ...... pe glycoproteins on the virus.
@en
P2093
P2860
P1433
P1476
N-terminal substitutions in HI ...... pe glycoproteins on the virus.
@en
P2093
Antu K Dey
John P Moore
Kathryn B David
Neelanjana Ray
Per J Klasse
Robert W Doms
Thomas J Ketas
P2860
P304
P356
10.1016/J.VIROL.2007.10.018
P407
P577
2007-11-26T00:00:00Z